The hammer makes me aware of nails.
TBH it’s a reasonable assumption in every developed country except one.
Having worked in the UK and in the US health systems, in general in the UK you have more of a risk of something that could be done, not being done (to save the government money).
Meanwhile, in the US, if you have good insurance, you are more at risk of over-testing and over-treatment (because it reduces the doctor’s perceived legal and complaint risk, and sometimes makes the doctor or hospital more money)
If this is true (and I think you're likely to be right) then we should see longer survival with GBM thanks to lead-time bias.
If the cancer is basically inoperable, or if there isn't a big difference in outcome based on time of detection, then there wouldn't be an appreciable change in survival rates
Lead time bias tells you that even if there is no effective treatment, you will appear to live longer thanks to earlier discovery of the disease. It was a hot topic with regard to prostate cancer a few years ago.
2) The article is vague and short but "cases of GBM in England have increased from around 1,250 a year in 1995 to just under 3,000" almost certainly refers to diagnosed cases of GBM, not including incidentals found in autopsies.
Glioblastomas are associated with Alzheimer's disease. Its entirely possible that 20 years ago the symptoms of a brain tumor would be attributed to Alzheimer's when the patient was already dying of Alzheimer's, or other terminal illness for that matter. With better awareness and detection we may pick up new diagnoses in the sick and dying.